Published

Meta-analysis supports DAPT de-escalation after PCI - Cardiovascular News

Summary by Cardiovascular News
Marco Valgimigli De-escalation to ticagrelor monotherapy does not increase ischaemic risk and reduces the risk of major bleeding when compared to 12 months of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), particularly among patients with acute coronary syndromes (ACS). This was the finding of a systematic review and individual patient data (IPD)-level meta-analysis of randomised trials comparing the safety …

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)